Robert A. Wise

Cyclophosphamide versus Placebo in Scleroderma Lung Disease

Donald P. Tashkin, Robert M. Elashoff, Philip J. Clements et al. · New England Journal of Medicine · 2006 · 1.6K citations · Full text

The Effects of a Smoking Cessation Intervention on 14.5-Year Mortality

Nicholas R. Anthonisen, M.A. Skeans, Robert A. Wise et al. · Annals of Internal Medicine · 2005 · 1.2K citations

Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD

David A. Lipson, Frank Barnhart, Noushin Brealey et al. · New England Journal of Medicine · 2018 · 1.2K citations · Full text

Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial

Donald P. Tashkin, Michael D. Roth, Philip J. Clements et al. · The Lancet Respiratory Medicine · 2016 · 1K citations · Full text

Sls Ii, Mycophenolate Mofetil, Inflammatory Lung Disease +9

Single-breath carbon monoxide diffusing capacity (transfer factor): Recommendations for a standard technique - 1995 update

Robert O. Crapo, J. Hankinson, Charles G. Irvin et al. · American Journal of Respiratory and Critical Care Medicine · 1995 · 594 citations

Ventilation, Air Quality, Gas Exchange Process +5